PropertyValue
?:effect
?:hasPrimarySource
?:impact
  • increase
?:interaction
  • The risk or severity of adverse effects can be increased when Clenoliximab is combined with Edrecolomab.
?:objectDrug
?:object_hasDrugBankID
?:precipitantDrug
?:precipitant_hasDrugBankID
is ?:subClassOf of
?:type

Metadata

Anon_0  
expand all